Jemyma Betrian

Recent publications · Crossref

5 total works indexed

1. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

   · 2021 · cited 209x

2. Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults

   · 2018 · cited 113x

3. A Phase II Redifferentiation Trial with Dabrafenib-Trametinib and 131I in Metastatic Radioactive Iodine Refractory <i>BRAF</i> p.V600E-Mutated Differentiated Thyroid Cancer

   · 2023 · cited 85x

4. Bendamustine is effective in T‐Cell prolymphocytic leukaemia

   · 2014 · cited 39x

5. PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study

   · 2023 · cited 34x

via Crossref · CC0